Sildenafil citrate for the treatment of patients with cardiovascular diseases with exclusion of coronary artery disease and hypertrophic subaortic stenosis
Its beneficial effect on patients chronic chagas's abd diabetic cardioneuromyopathies, hypertensive and hypertrophic cardiomyopathies, with or without chronic congestive heart failure
DOI:
https://doi.org/10.31053/1853.0605.v60.n2.36733Keywords:
.Abstract
.
Downloads
References
Goldstein I, Lue TF, PadmaNnathan H. oral sildenafil in the treatment of erectile dysfunction. N. Engl J. Med 1998;338:1397-1404.
NIH consensus development panel on impotence. NIH consensus conference: impotence. Jama 1993;270:83-90
Iosa D. chronic chagacic cardioneuropathy : pathogenesis and treatment: WHO and PAHO workshop: Chagas diseases and the nervous system. Scientific publication n 547 chapter 6. 1994.p 99-159
Ioda D DeQuattro V, de-Pink lee D. plasma norepiphrine in Chagas cardioneuromyophaty: a marker of progressive dysautonomía. Am Heart J. 1989; 117:882-87.
Guzzetti S, Iosa D, Pecis M. Impaired heart rate variability in patients with chronic Chagas disease. Am Heart J. 1991; 121:1727-34.
Iosa D, Caeiro T, Palmero H: Abnormal hyperventilation test in chronic Chagas disease. J Aut Nerv Syst. 1980; 2:87-92
Palmero H, Caeiro T, Iosa, D: The uniqueness of chronic Chagas disease. Medicina (B Aires). 1980;38:97-9.
Kolodny RC, Kahn CB, Goldstein H. Sexual dysfunction in diabetic men. Diabetes.1974;23:306-09
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The generation of derivative works is allowed as long as it is not done for commercial purposes. The original work may not be used for commercial purposes.
How to Cite
